Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma

Authors :: Fischer S
Tandstad T
Cohn-Cedermark G
Thibault C
Vincenzi B
Klingbiel D
Albany C
Necchi A
Terbuch A
Lorch A
Aparicio J
Heidenreich A
Hentrich M
Wheater M
Langberg CW
Ståhl O
Fankhauser CD
Hamid AA
Koutsoukos K
Shamash J
White J
Bokemeyer C
Beyer J
Gillessen S
Global Germ-Cell Cancer Group
Source :: JOURNAL OF CLINICAL ONCOLOGY, r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe, instname
Publication Year :: 2020
Publisher :: AMER SOC CLINICAL ONCOLOGY, 2020.
Abstract: Clinical stage I (CSI) nonseminoma (NS) is a disease limited to the testis without metastases. One treatment strategy after orchiectomy is adjuvant chemotherapy. Little is known about the outcome of patients who experience relapse after such treatment.

ISSN :: 0732183X
Database :: OpenAIRE
Journal :: JOURNAL OF CLINICAL ONCOLOGY, r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe, instname
Accession number :: edsair.RECOLECTA.....ce4c0bf208ed86b5c75a10ebac4c39c2

Tools